摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl]-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-1,4-dihydro-8-methoxy-4-oxoquinolin-3-carboxylic acid hydrochloride | 1193437-42-1

中文名称
——
中文别名
——
英文名称
7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl]-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-1,4-dihydro-8-methoxy-4-oxoquinolin-3-carboxylic acid hydrochloride
英文别名
——
7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl]-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-1,4-dihydro-8-methoxy-4-oxoquinolin-3-carboxylic acid hydrochloride化学式
CAS
1193437-42-1
化学式
C21H24FN3O4*ClH
mdl
——
分子量
437.899
InChiKey
FADCVVGVAGQFAF-YMOADCPFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

反应信息

  • 作为产物:
    描述:
    DX-619盐酸 作用下, 以 乙醇 为溶剂, 以83%的产率得到7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl]-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-1,4-dihydro-8-methoxy-4-oxoquinolin-3-carboxylic acid hydrochloride
    参考文献:
    名称:
    Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria
    摘要:
    A series of novel 6-desfluoro [des-F(6)] and 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methoxyquinolones bearing 3-(1-aminocycloalkyl)pyrrolidin-1-yl substituents at the C-7 position (1-6) was synthesized to obtain potent drugs for nosocomial infections caused by Gram-positive pathogens. The des-F(6) compounds 4-6 exhibited at least four times more potent activity against representative Gram-positive bacteria than ciprofloxacin or moxifloxacin. Among the derivatives, 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] derivative 4, which showed favorable profiles in preliminary toxicological and non-clinical pharmacokinetic studies, exhibited potent antibacterial activity against clinically isolated Gram-positive pathogens that had become resistant to one or more antibiotics. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.08.026
点击查看最新优质反应信息